Cargando…

Clinical and laboratory characteristics of drug-induced vasculitic syndromes

Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to...

Descripción completa

Detalles Bibliográficos
Autor principal: Wiik, Allan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257446/
https://www.ncbi.nlm.nih.gov/pubmed/16207347
http://dx.doi.org/10.1186/ar1805
_version_ 1782125808364552192
author Wiik, Allan
author_facet Wiik, Allan
author_sort Wiik, Allan
collection PubMed
description Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to spontaneous recovery, meaning that immunosuppressive therapy can be avoided. The presence of myeloperoxidase–antineutrophil cytoplasmic antibodies, IgM anticardiolipin antibody, and antihistone antibodies in combination was found to be characteristic of drug-induced vasculitic syndromes caused by the antithyroid drugs propylthiouracil and methimazol. Clinically, skin vasculitis and arthralgias predominated and renal vasculitis was rare.
format Text
id pubmed-1257446
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12574462005-10-19 Clinical and laboratory characteristics of drug-induced vasculitic syndromes Wiik, Allan Arthritis Res Ther Commentary Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to spontaneous recovery, meaning that immunosuppressive therapy can be avoided. The presence of myeloperoxidase–antineutrophil cytoplasmic antibodies, IgM anticardiolipin antibody, and antihistone antibodies in combination was found to be characteristic of drug-induced vasculitic syndromes caused by the antithyroid drugs propylthiouracil and methimazol. Clinically, skin vasculitis and arthralgias predominated and renal vasculitis was rare. BioMed Central 2005 2005-08-24 /pmc/articles/PMC1257446/ /pubmed/16207347 http://dx.doi.org/10.1186/ar1805 Text en Copyright © 2005 BioMed Central Ltd
spellingShingle Commentary
Wiik, Allan
Clinical and laboratory characteristics of drug-induced vasculitic syndromes
title Clinical and laboratory characteristics of drug-induced vasculitic syndromes
title_full Clinical and laboratory characteristics of drug-induced vasculitic syndromes
title_fullStr Clinical and laboratory characteristics of drug-induced vasculitic syndromes
title_full_unstemmed Clinical and laboratory characteristics of drug-induced vasculitic syndromes
title_short Clinical and laboratory characteristics of drug-induced vasculitic syndromes
title_sort clinical and laboratory characteristics of drug-induced vasculitic syndromes
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257446/
https://www.ncbi.nlm.nih.gov/pubmed/16207347
http://dx.doi.org/10.1186/ar1805
work_keys_str_mv AT wiikallan clinicalandlaboratorycharacteristicsofdruginducedvasculiticsyndromes